Search Result

Results for "

PO

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Akt (1) Amino Acid Derivatives (5) Amyloid-β (4) Apoptosis (3) Autophagy (6) Bacterial (1) Bcl-2 Family (1) Biochemical Assay Reagents (7) Bradykinin Receptor (1) Cytochrome P450 (1) Dopamine Receptor (1) Drug Derivative (1) Elastase (2) Endogenous Metabolite (5) Environmental Pollutants (2) Epigenetic Reader Domain (1) ERK (1) FLT3 (1) Fluorescent Dye (2) GABA Receptor (1) HSV (1) Indoleamine 2,3-Dioxygenase (IDO) (2) Isotope-Labeled Compounds (1) JNK (1) LIM Kinase (LIMK) (1) Lipoxygenase (1) mAChR (1) Mitophagy (1) MOFs (1) Monoamine Oxidase (1) NF-κB (2) Opioid Receptor (1) p38 MAPK (1) PAK (1) Parasite (1) PGE synthase (1) Phosphatase (1) PI3K (1) Platelet-activating Factor Receptor (PAFR) (1) Potassium Channel (1) PPAR (1) Reactive Oxygen Species (ROS) (2) Reference Standards (1) RET (1) Serotonin Transporter (1) Small Interfering RNA (siRNA) (2) Src (2) VEGFR (1) Virus Protease (1)
By Research Areas:	Cancer (15) Cardiovascular Disease (9) Endocrinology (1) Infection (3) Inflammation/Immunology (9) Metabolic Disease (9) Neurological Disease (9)
Oligonucleotides:	Human Pre-designed siRNA Sets (2) siRNAs (2)

Inhibitors & Agonists

Fluorescent Dyes

Biochemical Assay Reagents

Peptides

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-19824

3PO Maximum Cited Publications 29 Publications Verification	Autophagy	Cancer
3PO is an inhibitor of PFKFB3. 3PO attenuates the proliferation of several cancer cell lines with IC₅₀s of 1.4-24 μmol/L. 3PO suppresses glucose uptake and decreases the intracellular concentration of Fru-2,6-BP, lactate, ATP, NAD ⁺ and NADH. 3PO can be used for the research of cancer .

HY-N2581

Phytic acid sodium salt 1 Publications Verification myo-Inositol, hexakisdihydrogen phosphate sodium salt; Inositol hexaphosphate sodium salt	MOFs Endogenous Metabolite Amyloid-β Autophagy	Cardiovascular Disease Neurological Disease Metabolic Disease Cancer
Phytic acid (myo-Inositol; hexakis dihydrogen phosphate; Inositol hexaphosphate) sodium salt is an orally active compound. Phytic acid sodium salt can be derived from the seeds of legumes. Phytic acid sodium salt is a [PO4] ³- storage depot and precursor for other inositol phosphates and pyrophosphates. Phytic acid sodium salt attenuates Aβ oligomers and upregulates autophagy protein. Phytic acid sodium salt can be used in cardiovascular disease, metabolic disease, nervous system disease and cancer research .

HY-12204

PFK-015 3 Publications Verification	Autophagy	Metabolic Disease Inflammation/Immunology Cancer
PFK-015, a derivative of 3PO, is a specific PFKFB3 inhibitor. PFK-015 inhibits recombinant PFKFB3 with an IC₅₀ value of 110 nM and inhibits PFKFB3 activity in cancer cells with an IC₅₀ value of 20 nM. PFK-015 can be used for the research of multiple cancers such as lung cancer, stomach cancer, colon cancer and esophageal squamous cell carcinoma (ESCC) .

HY-N0814

Phytic acid (50% w/w in water) 1 Publications Verification Inositol hexaphosphate; SNF472 free acid	Endogenous Metabolite Amyloid-β Autophagy	Cardiovascular Disease Neurological Disease Metabolic Disease Cancer
Phytic acid (myo-Inositol; hexakis dihydrogen phosphate; Inositol hexaphosphate) is an orally active compound. Phytic acid can be derived from the seeds of legumes. Phytic acid is a [PO4] ³- storage depot and precursor for other inositol phosphates and pyrophosphates. Phytic acid attenuates Aβ oligomers and upregulates autophagy protein. Phytic acid can be used in cardiovascular disease, metabolic disease, nervous system disease and cancer research .

HY-103469

Peroxy Orange 1 3 Publications Verification PO1	Fluorescent Dye	Others
Peroxy Orange 1 (PO1) is a new H₂O₂ specific probe that can bind to green fluorescent highly reactive oxygen species (hROS) probe APF. Peroxy Orange 1 is also a living cell dye .

HY-160113

Sodium phosphate buffer 0.02 M, pH 6.9	Biochemical Assay Reagents	Others
Sodium phosphate buffer 0.02 M, pH 6.9 is a commonly used aqueous biological buffer that maintains a stable pH value. Sodium phosphate buffer 0.02 M, pH 6.9 is often used in enzyme activity assays, such as α-amylase assays. Sodium phosphate buffer 0.02 M, pH 6.9 is prepared by mixing disodium hydrogen phosphate (Na₂HPO₄) (HY-B2243) and sodium dihydrogen phosphate (NaH₂PO₄) (HY-Y0308) to a total concentration of 0.02 M .

HY-15652

Freselestat ONO-6818; ONO-PO-736	Elastase	Inflammation/Immunology
Freselestat (ONO-6818) is a potent and orally active neutrophil elastase inhibitor with a K_i of 12.2 nM. Freselestat is >100-fold less-active against other proteases such as trypsin, protein-ase 3, pancreatic elastase, plasmin, thrombin, collagenase, cathepsin G, and murine macrophage elastase. Freselestat has a potent anti-inflammatory activity .

HY-W008908

Fmoc-Tyr(H2PO3)-OH	Amino Acid Derivatives	Others
Fmoc-Tyr(H2PO3)-OH is a tyrosine derivative .

HY-155998

NF-κB-IN-11 1 Publications Verification	NF-κB	Inflammation/Immunology
NF-κB-IN-11 (Compound 3i) is a NF-κB inhibitor. NF-κB-IN-11 inhibits TNF-α induced activation of NF-κB pathway, and inhibits nuclear translocation of NF-κB. NF-κB-IN-11 down-regulates the expression levels of phosphor-IKK, IκBα, and NF-κB p65. NF-κB-IN-11 has anti-inflammatory activity, and alleviates dextran sulfate sodium-induced colitis in mice. NF-κB-IN-11 (p.o.) shows a MTD more than 1852 mg/kg in mice acute toxicity assay .

HY-W011778

H-Tyr(H2PO3)-OH	Amino Acid Derivatives	Others
H-Tyr(H2PO3)-OH is a tyrosine derivative .

HY-160113B

Sodium phosphate buffer 0.1M, pH 6.8	Biochemical Assay Reagents	Others
Sodium phosphate buffer 0.1M, pH 6.8 is mainly composed of two phosphates, Na₂HPO₄ and NaH₂PO₄, with a total phosphate concentration of 0.1 M, which mainly acts as a buffer in the reaction.

HY-N2580

Zinc Phytate 1 Publications Verification	Endogenous Metabolite Amyloid-β Autophagy	Cardiovascular Disease Neurological Disease Metabolic Disease Cancer
Zinc Phytate (myo-Inositol; hexakis dihydrogen phosphate; Inositol hexaphosphate) is an orally active compound. Zinc Phytate can be derived from the seeds of legumes. Zinc Phytate is a [PO4] ³- storage depot and precursor for other inositol phosphates and pyrophosphates. Zinc Phytate attenuates Aβ oligomers and upregulates autophagy protein. Zinc Phytate can be used in cardiovascular disease, metabolic disease, nervous system disease and cancer research .

HY-N0469R

L-Lysine (Standard)	Reference Standards Endogenous Metabolite Virus Protease HSV	Infection Metabolic Disease Inflammation/Immunology
L-Lysine (Standard) is the analytical standard of L-Lysine. This product is intended for research and analytical applications. L-lysine is an essential amino acid for humans with orally activity. L-lysine can inhibit the occurrence of HSV infections and is used in herpes research. L-lysine increases calcium absorption, reduces diabetes-related diseases, improves gut health, and alleviates pancreatic inflammation. L-lysine can be used in research on metabolism, infection, and inflammation . IC₅₀ & Target:L-lysine (150 mg/kg) promotes, but not initiates, bladder cancer. The administration of L-lysine to rats submitted to colovesical cystoplasty accelerates the development of transitional metaplasia of the intestinal epithelium . L-lysine (10 mg/kg) treatment attenuates pancreatic tissue injury induced by L-arginine by inhibiting the release of the inflammatory cytokine IL-6 and enhance antioxidant activity . In Vivo:L-lysine (10?mg/kg, p.o., pre-treated or post-treated, administration duration 15 days) treatment attenuates pancreatic tissue injury induced by L-arginine by inhibiting the release of the inflammatory cytokine IL-6 and enhance antioxidant activity in acute pancreatitis mice model . L-lysine (5 or 10?mg/kg, p.o., 45 days) ameliorates sepsis-induced acute lung injury in a lipopolysaccharide (HY-D1056)-induced mouse model .

HY-W010770

Fmoc-Thr[PO(OBzl)OH]-OH	Amino Acid Derivatives	Others
Fmoc-Thr[PO(OBzl)OH]-OH is a threonine derivative .

HY-W141821

Fmoc-Phe(CF2PO3)-OH	Amino Acid Derivatives	Others
Fmoc-Phe(CF2PO3)-OH is a phenylalanine derivative .

HY-15791

FR173657 FK-3657	Bradykinin Receptor	Inflammation/Immunology
FR173657 is an orally active bradykinin B2 receptor antagonist (IC₅₀: 0.56, 1.5, 2.9 nM for pig, rat, human B2 receptor respectively). FR173657 (p.o.) inhibits BK-induced bronchoconstriction in guinea-pigs (ED₅₀: 0.075 mg/kg). FR173657 (p.o.) also inhibits Carrageenin-induced paw oedema in mice (ED₅₀: 6.8 mg/kg). FR173657 can be used for research of inflammatory disease .

HY-160113D

Sodium phosphate buffer 0.1M, pH 7.5	Biochemical Assay Reagents	Others
Sodium phosphate buffer 0.1M, pH 7.5 is mainly composed of two phosphates, Na₂HPO₄ and NaH₂PO₄, with a total phosphate concentration of 0.1 M, which mainly acts as a buffer in the reaction.

HY-110169

(E/Z)-3PO	Phosphatase	Cardiovascular Disease Cancer
(E/Z)-3PO is a potent PFKFB3 inhibitor. (E/Z)-3PO can inhibit the glycolysis process, reduce the extracellular acidification rate, and inhibit the capillary tube formation, migration of endothelial cells, and the formation of aortic sprouts, thereby suppressing angiogenesis. (E/Z)-3PO is promising for research of diseases such as cancer, acute lung injury, pulmonary fibrosis, and atherosclerosis .

HY-Y1322S

Triphenyl phosphate-d15 Celluflex TPP-d₁₅; DHPF 005-d₁₅; Disflamol TP-d₁₅; Disflamoll TP-d₁₅; NSC 57868-d₁₅; Phenyl phosphate ((PhO)3PO)-d₁₅; Phoscon FR 903N-d₁₅	Isotope-Labeled Compounds Environmental Pollutants ERK Indoleamine 2,3-Dioxygenase (IDO) p38 MAPK NF-κB Akt Monoamine Oxidase Mitophagy Reactive Oxygen Species (ROS) JNK PI3K PPAR Apoptosis	Cardiovascular Disease Neurological Disease Metabolic Disease Inflammation/Immunology Endocrinology
Triphenyl phosphate-d₁₅ is the deuterium labeled Triphenyl phosphate. Triphenyl phosphate is an orally active, blood-brain barrier-permeable aryl organophosphate flame retardant and endocrine disruptor. Triphenyl phosphate disrupts mitochondrial dynamic balance through oxidative stress, induces excessive mitophagy and apoptosis, and ultimately leads to myocardial fibrosis. In the brain, Triphenyl phosphate activates the NF-κB inflammatory pathway by disrupting the gut microbiota, alters tryptophan metabolism and elevates neurotoxins, thereby inducing anxiety- and depression-like behaviors. In the skeletal and reproductive systems, Triphenyl phosphate inhibits osteoblast differentiation and induces germ cell apoptosis by suppressing the MAPK/ERK pathway and activating the JNK signal, respectively. In adipose and placental tissues, Triphenyl phosphate promotes lipid accumulation by activating the PI3K/AKT-PPARγ axis, and disrupts placental metabolism via the MAOA/ROS/NF-κB cascade, impairing neurodevelopment of offspring.

HY-N7504

Isopsoralenoside	Bacterial	Infection Metabolic Disease Cancer
Isopsoralenoside is a benzofuran glycoside from Psoralea corylifolia. Isopsoralenoside can be quickly metabolized to Psoralen (HY-N0053) in digestive tract contents. Isopsoralenoside show estrogen-like activity, osteoblastic proliferation accelerating activity, antitumor effects and antibacterial activity .

HY-15652A

Freselestat quarterhydrate ONO-6818 quarterhydrate; ONO-PO-736 quarterhydrate	Elastase	Inflammation/Immunology
Freselestat quarterhydrate (ONO-6818 quarterhydrate) is a potent and orally active neutrophil elastase inhibitor with a K_i of 12.2 nM. Freselestat quarterhydrate is >100-fold less-active against other proteases such as trypsin, protein-ase 3, pancreatic elastase, plasmin, thrombin, collagenase, cathepsin G, and murine macrophage elastase. Freselestat quarterhydrate has a potent anti-inflammatory activity .

HY-160113C

Sodium phosphate buffer 0.1M, pH 7.2	Biochemical Assay Reagents	Others
Sodium phosphate buffer 0.1M, pH 7.2 is mainly composed of two phosphates, Na₂HPO₄ and NaH₂PO₄, with a total phosphate concentration of 0.1 M, which mainly acts as a buffer in the reaction.

HY-160113A

Sodium phosphate buffer 0.1M, pH 6.0	Biochemical Assay Reagents	Others
Sodium phosphate buffer 0.1M, pH 6.0 is mainly composed of two phosphates, Na₂HPO₄ and NaH₂PO₄, with a total phosphate concentration of 0.1 M, which mainly acts as a buffer in the reaction.

HY-169937

(R)-SR-C-107	Epigenetic Reader Domain	Cancer
(R)-SR-C-107 is an orally available inhibitor of ENL (YEAST domain-containing protein) designed to target acute myeloid leukemia (AML). (R)-SR-C-107 targets ENL with IC₅₀ and K_D of 40 nM and 144 nM, respectively. (R)-SR-C-107 demonstrates in vivo efficacy in a xenograft mouse model of AML, with a tumor regression rate of 45% at a dose of 200 mg/kg (PO; QD) .

HY-W762012

Octachlorodibenzo-p-dioxin OCDD	Cytochrome P450 Environmental Pollutants	Others
Octachlorodibenzo-p-dioxin (OCDD) is an environmental contaminant but is not acutely toxic. In rats, Octachlorodibenzo-p-dioxin (50 μg/kg i.v. or 50-5000 μg/kg p.o.) has a systemic elimination half-life of 3-5 months and accumulates and concentrates in the liver and adipose tissue after low-dose, repeated exposure. Repeated administration of octachlorodibenzo-p-dioxin causes increases in 7-ethoxyresorufin-O-deethylase (7-EROD) activity and total cytochrome P-450 levels .

HY-159897

PAK4-IN-5	PAK LIM Kinase (LIMK) Apoptosis Reactive Oxygen Species (ROS)	Cancer
PAK4-IN-5 (Compound 12i) is a PAK4 inhibitor (IC₅₀: 7.68 nM for PAK4, 1872.01 nM for PAK1). PAK4-IN-5 binds to PAK4 stably via multiple interactions. PAK4-IN-5 inhibits the proliferation and the migratory potential of MDA-MB-231 cells by inhibiting the phosphorylation of PAK4 and LIMK1. PAK4-IN-5 arrests cell cycle in the G0/G1 phase, induces apoptosis and ROS production. LD₅₀: >500 mg/kg for mice (p.o.) .

HY-155238

E2730	GABA Receptor	Neurological Disease
E2730 is a noncompetitive but selective inhibitor of gamma-aminobutyric acid (GABA) transporter 1 (GAT1) with orally available and antiepileptic activity. E2730-mediated GAT1 inhibition is positively correlated with environmental GABA levels and selectively inhibits GAT1-mediated GABA uptake. E2730 (5-50 mg/kg; po) in rat amygdala ignition model, and in mouse cornea ignition (5-50 mg/kg), drug resistance 6Hz-44mA has demonstrated in vivo efficacy in models of psychomotor epilepsy (5-50 mg/kg), fragile X syndrome (2.5-300 mg/kg), and Dravet syndrome (10 mg/kg, 20 mg/kg) .

HY-W142086

Fmoc-Ser(PO(NHPr)2)-OH	Amino Acid Derivatives	Others
Fmoc-Ser(PO(NHPr)2)-OH is a serine derivative .

HY-RS01213

ATP5PO Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ATP5PO Human Pre-designed siRNA Set A contains three designed siRNAs for ATP5PO gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ATP5PO Human Pre-designed siRNA Set A ATP5PO Human Pre-designed siRNA Set A

HY-P1200

Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH	Src	Cancer
Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH (compound 1) is a high-affinity pentapeptide to bind to the src SH2 domain (IC₅₀≈1 µM). Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH is an inhibitor for src SH3-SH2:phosphoprotein interactions .

HY-P1200A

Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH TFA	Src	Cancer
Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH TFA (compound 1) is a high-affinity pentapeptide to bind to the src SH2 domain (IC₅₀≈1 µM). Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH TFA is an inhibitor for src SH3-SH2:phosphoprotein interactions .

HY-P3480

H-Trp-Phe-Tyr-Ser(PO3H2)-Pro-Arg-pNA	Fluorescent Dye	Others
H-Trp-Phe-Tyr-Ser(PO3H2)-Pro-Arg-pNA is a chromogenic substrate for Pin1. Pin1 is an essential and conserved mitotic peptidyl-prolyl isomerase, and can recognize the phosphoserine-proline bonds present in mitotic phosphoproteins .

HY-RS11054

PRB4 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
PRB4 Human Pre-designed siRNA Set A contains three designed siRNAs for PRB4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PRB4 Human Pre-designed siRNA Set A PRB4 Human Pre-designed siRNA Set A

HY-120045A

DuP 747 hydrochloride	Opioid Receptor	Neurological Disease
DuP 747 hydrochloride is an analgesic with selective kappa-opioid receptor agonist activity. DuP 747 showed less spiradoline-appropriate selection when administered SC, but showed a partial generalized response to spiradoline when administered IP or PO. The 5-hydroxy-desmethoxy metabolite of DuP 747 induced selection of the saline-appropriate lever only. The effects of DuP 747 suggest that its metabolites may play a major role in the similar responses to spiradoline after IP and PO administration .

HY-101694

Siltenzepine AWD 26-06 free base	mAChR	Inflammation/Immunology
Siltenzepine (AWD 26-06 free base) is an antagonist of mAChR with anti-acid activity, which can be used in peptic ulcers research. Siltenzepine exhibits rapidly but incompletely absorbed characterastic in rats (po) .

HY-149539

PLM-101	FLT3 RET	Cancer
PLM-101 is an orally available anticancer agent targeting FLT3 and RET with inhibitory activity against acute myeloid leukemia cells. PLM-101 inhibits RET, thereby inducing autophagic degradation of FLT3; and it inhibits the PI3K and Ras/ERK pathways, resulting in anti-leukemia activity. PLM-101 has anti-tumor efficacy in a mouse MV4-11 flank xenograft model (dose: 3, 10 mg/kg; po) and an allogeneic xenograft mouse model (dose: 40 mg/kg; po) .

HY-162498

Antileishmanial agent-29	Parasite	Infection
Antileishmanial agent-29 (Compound 110) is an orally active antileishmanial agent. Antileishmanial agent-29 (p.o., 40, 60 mg/kg, 10 days) protects mice from leishmania infection .

HY-115826

AB-163	Biochemical Assay Reagents	Cancer
AB-163 is an alkylating agent with anti-tumor activity. AB-163 exerts LD₅₀s of 198 (p.o.) and 159 (i.p.) mg/kg in ICR/Ha male mice and can be utilized in cancer research .

HY-19141

L-691121	Potassium Channel	Cardiovascular Disease
L-691121 exhibits antiarrhythmic efficacy through block of potassium channel and a followed prolonged cardiac potential. L-691121 exhibits embryotoxicity with fetal mortality at the dose of 0.8 mg/kg/day (p.o.). L-691121 is orally active .

HY-N8458

Cryogenine NSC 272693	PGE synthase	Inflammation/Immunology
Cryogenine is an alkaloid originally isolated from H. salicifolia that has anti-inflammatory activity. It inhibits prostaglandin synthetase (IC₅₀=424 μM). Cryogenine (100 mg/kg per day, p.o.) reduces paw edema and the mean arthritic index in a rat model of adjuvant-induced polyarthritis.

HY-106194

SLV310	Dopamine Receptor Serotonin Transporter	Neurological Disease
SLV310 is an orally active dopamine D2 receptor antagonist (K_i: 5 nM) and serotonin reuptake receptor inhibitor. SLV310 antagonizes Apomorphine (HY-12723) induced climbing behaviour and 5-HTP (HY-N0122) induced serotonin syndrome like behaviour in mice (ED₅₀: 5.6 and 5.9 mg/kg, p.o.). SLV310 is an antipsychotic compound and can be used for schizophrenia research .

HY-N15424

Himachalol	Apoptosis Bcl-2 Family
Himachalol, a sesquiterpene, is an orally active antispasmodic and anticancer constituent found in the wood of Cedrus deodara. Himachalol has anti-proliferative activity against the melanoma cells, and induces apoptosis (decreases Bcl-2 level and increases Bax level). Himachalol has systemic hypotension and peripheral vasodilation effect. Himachalol inhibits Carbachol-induced spasm of the intestine. The LD₅₀ of Himachalol in mice is 265 mg/kg (p.o.) and 247 mg/kg (i.p.) .

HY-121586

Nafazatrom Bay g 6575	Lipoxygenase	Cardiovascular Disease
Nafazatrom (Bay g 6575) is an orally active cardioprotective agent that protects against ischemic damage. Nafazatrom dose-dependently inhibits neutrophil aggregation, superoxide anion generation, arachidonic acid metabolism, and to a lesser extent the release of β-glucosidase, platelet aggregation or arachidonic acid in vitro. Acid metabolism has no significant effect. In a dog ischemia-reperfusion model, Nafazatrom (10 mg/kg; po) reduced infarct size and the occurrence of arrhythmias and rescued ischemic myocardial function without affecting any hemodynamic changes. The basis of Nafazatrom's cardioprotection may be inhibition of neutrophil function and cellular infiltration in vitro .

HY-117811

(R,R)-MK 287 L-680574	Platelet-activating Factor Receptor (PAFR)	Cardiovascular Disease
(R,R)-MK 287 (L-680574) is a tetrahydrofuran derivative that potently inhibits the binding of [3H]C18-PAF to human platelets, polymorphonuclear leukocytes (PMNs), and lung membranes with Ki values of 6.1, 3.2, and 5.49 nM, respectively. (R,R)-MK 287 potently and selectively inhibits PAF-induced platelet aggregation (ED₅₀=56 nM) and elastase release from PMNs (ED₅₀=4.4 nM). (R,R)-MK 287 inhibits PAF-induced lethality in mice (ED₅₀=0.8 mg/kg, po) and PAF-induced bronchospasm in guinea pigs (ED₅₀=0.18 mg/kg) .

HY-117991

DW10075	VEGFR	Cancer
DW10075 is a highly selective and orally active VEGFR inhibitor targeting the VEGF/VEGFR pathway. DW10075 selectively inhibits VEGFR-1, VEGFR-2, and VEGFR-3, but has no effect on FGFR and PDGFR. DW10075 inhibits VEGF-induced HUVEC proliferation, migration, and tube formation. And DW10075 inhibits angiogenesis in both the rat aortic ring model and the chick chorionic membrane model. DW10075 also exhibits antiproliferative activity against human cancer cell lines, with IC₅₀s of 2.2 μM and 22.2 μM against U87-MG human glioblastoma cells and A375 melanoma cells, respectively. In the nude mouse U87-MG xenograft tumor model, DW10075 (po) significantly inhibits tumor growth and reduces the expression of CD31 and Ki67 in tumor tissues.

HY-49637

Biotin-PEG6-PO(F)-C16	Biochemical Assay Reagents	Others
Biotin-PEG6-PO (F)-C16 is an activity-based proteomics probe .

HY-P11620

H-Asn-Pro-Glu-Tyr(PO3H2)-OH	Drug Derivative	Others
H-Asn-Pro-Glu-Tyr(PO3H2)-OH is a phosphorylated peptide derivative of the tetramine motif Asn-Pro-Glu-Tyr (NPEY), and is a substrate binding domain common to the insulin-like growth factor-I receptor (IGF-IR) and the insulin receptor (IR).

HY-148336A

IDO1/TDO-IN-5	Indoleamine 2,3-Dioxygenase (IDO)	Others
IDO1/TDO-IN-5 (compound 9p-O) is a potent dual IDO1/TDO inhibitor with IC₅₀ valeus of 18 and 25 nM, respectively .

HY-181448

Phytic acid hexalithium Inositol hexaphosphate hexalithium; SNF472 hexalithium	Endogenous Metabolite Amyloid-β Autophagy	Cardiovascular Disease Neurological Disease Metabolic Disease Cancer
Phytic acid (Inositol hexaphosphate hexalithium) hexalithium is an orally active compound. Phytic acid hexalithium can be derived from the seeds of legumes. Phytic acid is a [PO4] ³- storage depot and precursor for other inositol phosphates and pyrophosphates. Phytic acid hexalithium attenuates Aβ oligomers and upregulates Autophagy protein. Phytic acid hexalithium can be used in cardiovascular disease, metabolic disease, nervous system disease and cancer research .

Cat. No.	Product Name	Type

HY-103469

Peroxy Orange 1 3 Publications Verification PO1	Fluorescent Dyes
Peroxy Orange 1 (PO1) is a new H₂O₂ specific probe that can bind to green fluorescent highly reactive oxygen species (hROS) probe APF. Peroxy Orange 1 is also a living cell dye .

Cat. No.	Product Name	Type

HY-160113

Sodium phosphate buffer 0.02 M, pH 6.9

Biochemical Assay Reagents

Sodium phosphate buffer 0.02 M, pH 6.9 is a commonly used aqueous biological buffer that maintains a stable pH value. Sodium phosphate buffer 0.02 M, pH 6.9 is often used in enzyme activity assays, such as α-amylase assays. Sodium phosphate buffer 0.02 M, pH 6.9 is prepared by mixing disodium hydrogen phosphate (Na₂HPO₄) (HY-B2243) and sodium dihydrogen phosphate (NaH₂PO₄) (HY-Y0308) to a total concentration of 0.02 M .

HY-160113B

Sodium phosphate buffer 0.1M, pH 6.8	Biochemical Assay Reagents
Sodium phosphate buffer 0.1M, pH 6.8 is mainly composed of two phosphates, Na₂HPO₄ and NaH₂PO₄, with a total phosphate concentration of 0.1 M, which mainly acts as a buffer in the reaction.

HY-160113D

Sodium phosphate buffer 0.1M, pH 7.5	Biochemical Assay Reagents
Sodium phosphate buffer 0.1M, pH 7.5 is mainly composed of two phosphates, Na₂HPO₄ and NaH₂PO₄, with a total phosphate concentration of 0.1 M, which mainly acts as a buffer in the reaction.

HY-160113C

Sodium phosphate buffer 0.1M, pH 7.2	Biochemical Assay Reagents
Sodium phosphate buffer 0.1M, pH 7.2 is mainly composed of two phosphates, Na₂HPO₄ and NaH₂PO₄, with a total phosphate concentration of 0.1 M, which mainly acts as a buffer in the reaction.

HY-160113A

Sodium phosphate buffer 0.1M, pH 6.0	Biochemical Assay Reagents
Sodium phosphate buffer 0.1M, pH 6.0 is mainly composed of two phosphates, Na₂HPO₄ and NaH₂PO₄, with a total phosphate concentration of 0.1 M, which mainly acts as a buffer in the reaction.

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N2581

Phytic acid sodium salt 1 Publications Verification myo-Inositol, hexakisdihydrogen phosphate sodium salt; Inositol hexaphosphate sodium salt	Structural Classification Natural Products Zea mays L. Classification of Application Fields Gramineae Other Diseases Plants Disease Research Fields Source Classification	MOFs Endogenous Metabolite Amyloid-β Autophagy
Phytic acid (myo-Inositol; hexakis dihydrogen phosphate; Inositol hexaphosphate) sodium salt is an orally active compound. Phytic acid sodium salt can be derived from the seeds of legumes. Phytic acid sodium salt is a [PO4] ³- storage depot and precursor for other inositol phosphates and pyrophosphates. Phytic acid sodium salt attenuates Aβ oligomers and upregulates autophagy protein. Phytic acid sodium salt can be used in cardiovascular disease, metabolic disease, nervous system disease and cancer research .

HY-N0814

Phytic acid (50% w/w in water) 1 Publications Verification Inositol hexaphosphate; SNF472 free acid	Structural Classification other families Neurological Disease Classification of Application Fields Food Preservation Research Ketones, Aldehydes, Acids Plants Endogenous metabolite Inflammation/Immunology Disease Research Fields Source Classification Agricultural Research	Endogenous Metabolite Amyloid-β Autophagy
Phytic acid (myo-Inositol; hexakis dihydrogen phosphate; Inositol hexaphosphate) is an orally active compound. Phytic acid can be derived from the seeds of legumes. Phytic acid is a [PO4] ³- storage depot and precursor for other inositol phosphates and pyrophosphates. Phytic acid attenuates Aβ oligomers and upregulates autophagy protein. Phytic acid can be used in cardiovascular disease, metabolic disease, nervous system disease and cancer research .

HY-N2580

Zinc Phytate 1 Publications Verification	Natural Products other families Classification of Application Fields Other Diseases Plants Disease Research Fields Source Classification	Endogenous Metabolite Amyloid-β Autophagy
Zinc Phytate (myo-Inositol; hexakis dihydrogen phosphate; Inositol hexaphosphate) is an orally active compound. Zinc Phytate can be derived from the seeds of legumes. Zinc Phytate is a [PO4] ³- storage depot and precursor for other inositol phosphates and pyrophosphates. Zinc Phytate attenuates Aβ oligomers and upregulates autophagy protein. Zinc Phytate can be used in cardiovascular disease, metabolic disease, nervous system disease and cancer research .

HY-N0469R

L-Lysine (Standard)	Structural Classification Microorganisms Disease markers Endocrine diseases Amino acids Nervous System Disorder Endogenous metabolite Source Classification	Reference Standards Endogenous Metabolite Virus Protease HSV
L-Lysine (Standard) is the analytical standard of L-Lysine. This product is intended for research and analytical applications. L-lysine is an essential amino acid for humans with orally activity. L-lysine can inhibit the occurrence of HSV infections and is used in herpes research. L-lysine increases calcium absorption, reduces diabetes-related diseases, improves gut health, and alleviates pancreatic inflammation. L-lysine can be used in research on metabolism, infection, and inflammation . IC₅₀ & Target:L-lysine (150 mg/kg) promotes, but not initiates, bladder cancer. The administration of L-lysine to rats submitted to colovesical cystoplasty accelerates the development of transitional metaplasia of the intestinal epithelium . L-lysine (10 mg/kg) treatment attenuates pancreatic tissue injury induced by L-arginine by inhibiting the release of the inflammatory cytokine IL-6 and enhance antioxidant activity . In Vivo:L-lysine (10?mg/kg, p.o., pre-treated or post-treated, administration duration 15 days) treatment attenuates pancreatic tissue injury induced by L-arginine by inhibiting the release of the inflammatory cytokine IL-6 and enhance antioxidant activity in acute pancreatitis mice model . L-lysine (5 or 10?mg/kg, p.o., 45 days) ameliorates sepsis-induced acute lung injury in a lipopolysaccharide (HY-D1056)-induced mouse model .

HY-N7504

Isopsoralenoside	Infection Classification of Application Fields Leguminosae Ketones, Aldehydes, Acids Metabolic Disease Psoralea corylifolia L. Plants Disease Research Fields Source Classification	Bacterial
Isopsoralenoside is a benzofuran glycoside from Psoralea corylifolia. Isopsoralenoside can be quickly metabolized to Psoralen (HY-N0053) in digestive tract contents. Isopsoralenoside show estrogen-like activity, osteoblastic proliferation accelerating activity, antitumor effects and antibacterial activity .

HY-N15424

Himachalol	Cedrus deodara (Roxburgh) G. Don Pinaceae Terpenoids Sesquiterpenes Plants Source Classification	Apoptosis Bcl-2 Family
Himachalol, a sesquiterpene, is an orally active antispasmodic and anticancer constituent found in the wood of Cedrus deodara. Himachalol has anti-proliferative activity against the melanoma cells, and induces apoptosis (decreases Bcl-2 level and increases Bax level). Himachalol has systemic hypotension and peripheral vasodilation effect. Himachalol inhibits Carbachol-induced spasm of the intestine. The LD₅₀ of Himachalol in mice is 265 mg/kg (p.o.) and 247 mg/kg (i.p.) .

Species:	Human (5) Rat (2)
Tag:	His (3) Tag Free (1) GST (2)
Source:	HEK293 (1) E. coli (6)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P76943A

	Galectin-8/LGALS8 Protein, Rat (His) Galectin-8; Gal-8; PO66 Carbohydrate-Binding Protein; PO66-CBP; Prostate Carcinoma Tumor Antigen 1; PCTA-1; LGALS8	Rat	E. coli
	Galectin-8 belongs to the family of animal lectins that bind to different glycoconjugates. Galectin-8 inhibits MTOR and AMPK signaling pathways to induce autophagy in response to lysosomal damage. Galectin-8 is highly expressed in a variety of tumors. Galectin-8 Protein, Rat (His) is the recombinant rat-derived Galectin-8, expressed by E. coli, with N-6His labeled tag. The total length of Galectin-8 Protein, Rat (His) is 316 a.a.*.

HY-P76943

	Galectin-8/LGALS8 Protein, Rat (GST) Galectin-8; Gal-8; PO66 Carbohydrate-Binding Protein; PO66-CBP; Prostate Carcinoma Tumor Antigen 1; PCTA-1; LGALS8	Rat	E. coli
	Galectin-8 belongs to the family of animal lectins that bind to different glycoconjugates. Galectin-8 inhibits MTOR and AMPK signaling pathways to induce autophagy in response to lysosomal damage. Galectin-8 is highly expressed in a variety of tumors. Galectin-8/LGALS8 Protein, Rat (GST) is the recombinant rat-derived Galectin-8 protein, expressed by E. coli , with N-GST labeled tag.

HY-P70190

	Galectin-8/LGALS8 Protein, Human rHuGalectin-8; Galectin-8; Gal-8; PO66 Carbohydrate-Binding Protein; PO66-CBP; Prostate Carcinoma Tumor Antigen 1; PCTA-1; LGALS8	Human	E. coli
	Galectin-8/LGALS8 protein is an important enzyme in the glycosylation process, acting as β-1,3-N-acetylglucosaminyltransferase to synthesize poly-N-acetyllactosamine. Galectin-8/LGALS8 is essential for modifying glycoproteins and glycolipids, catalyzes the transfer of N-acetylglucosamine to acceptor molecules, and exhibits specific activity on type 2 oligosaccharides. Galectin-8/LGALS8 Protein, Human is the recombinant human-derived Galectin-8/LGALS8 protein, expressed by E. coli , with tag free.

HY-P700081AF

	Animal-Free Galectin-8/LGALS8 Protein, Human (His) Galectin-8; Galectin-8; Gal-8; PO66 Carbohydrate-Binding Protein; PO66-CBP; Prostate Carcinoma Tumor Antigen 1; PCTA-1; LGALS8	Human	E. coli
	Galectin-8/LGALS8 protein is an important enzyme in the glycosylation process, acting as β-1,3-N-acetylglucosaminyltransferase to synthesize poly-N-acetyllactosamine. Galectin-8/LGALS8 is essential for modifying glycoproteins and glycolipids, catalyzes the transfer of N-acetylglucosamine to acceptor molecules, and exhibits specific activity on type 2 oligosaccharides. Animal-Free Galectin-8/LGALS8 Protein, Human (His) is the recombinant human-derived animal-FreeGalectin-8/LGALS8 protein, expressed by E. coli , with N-His labeled tag. This product is for cell culture use only.

HY-P700382

	Galectin-8/LGALS8 Protein, Human (GST) LGALS8; lectin, galactoside-binding, soluble, 8; galectin-8; galectin 8; PCTA 1; galectin-8g; PO66 carbohydrate binding protein; PO66 carbohydrate-binding protein; prostate carcinoma tumor antigen 1; Gal-8; PCTA1; PCTA-1; PO66-CBP	Human	E. coli
	Galectin-8/LGALS8 protein is an important enzyme in the glycosylation process, acting as β-1,3-N-acetylglucosaminyltransferase to synthesize poly-N-acetyllactosamine. Galectin-8/LGALS8 is essential for modifying glycoproteins and glycolipids, catalyzes the transfer of N-acetylglucosamine to acceptor molecules, and exhibits specific activity on type 2 oligosaccharides. Galectin-8/LGALS8 Protein, Human (GST) is the recombinant human-derived Galectin-8/LGALS8 protein, expressed by E. coli , with N-GST labeled tag.

HY-P71917

	P4HB Protein, Human (His) 1 Publications Verification Cellular thyroid hormone binding protein; Cellular thyroid hormone-binding protein; Collagen prolyl 4 hydroxylase beta; Disulphide Isomerase; DSI; EC 5.3.4.1; ER protein 59; ERBA2L; ERp59; GIT; P4HB; P4Hbeta; p55; PDI; PDIA1; PDIA1_HUMAN; PDIR; PHDB; PO4DB; PO4HB; PROHB; Protocollagen hydroxylase; Thbp;	Human	E. coli
	The P4HB protein is a multifunctional entity that catalyzes disulfide bonding processes at the cell surface and within cells. As a reductase, it modifies outer surface proteins and participates in the formation of disulfide bonds in nascent proteins. P4HB Protein, Human (His) is the recombinant human-derived P4HB protein, expressed by E. coli , with N-6*His labeled tag.

HY-P71087

	P4HB Protein, Human (HEK293, His) Protein Disulfide-Isomerase; PDI; Cellular Thyroid Hormone-Binding Protein; Prolyl 4-Hydroxylase Subunit Beta; p55; P4HB; ERBA2L; PDI; PDIA1; PO4DB	Human	HEK293
	The P4HB protein is a multifunctional entity that catalyzes disulfide bonding processes at the cell surface and within cells. As a reductase, it modifies outer surface proteins and participates in the formation of disulfide bonds in nascent proteins. P4HB Protein, Human (HEK293, His) is the recombinant human-derived P4HB protein, expressed by HEK293 , with C-6*His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-Y1322S

Triphenyl phosphate-d15

Triphenyl phosphate-d₁₅ is the deuterium labeled Triphenyl phosphate. Triphenyl phosphate is an orally active, blood-brain barrier-permeable aryl organophosphate flame retardant and endocrine disruptor. Triphenyl phosphate disrupts mitochondrial dynamic balance through oxidative stress, induces excessive mitophagy and apoptosis, and ultimately leads to myocardial fibrosis. In the brain, Triphenyl phosphate activates the NF-κB inflammatory pathway by disrupting the gut microbiota, alters tryptophan metabolism and elevates neurotoxins, thereby inducing anxiety- and depression-like behaviors. In the skeletal and reproductive systems, Triphenyl phosphate inhibits osteoblast differentiation and induces germ cell apoptosis by suppressing the MAPK/ERK pathway and activating the JNK signal, respectively. In adipose and placental tissues, Triphenyl phosphate promotes lipid accumulation by activating the PI3K/AKT-PPARγ axis, and disrupts placental metabolism via the MAOA/ROS/NF-κB cascade, impairing neurodevelopment of offspring.

Host:	Rat (1) Mouse (7) Rabbit (4)
Reactivity:	Human (10) Rat (5) Mouse (7)
Application:	IHC-P (12) ICC/IF (6) IP (1) IHC-F (4) WB (9) FC (5) ELISA (5)
Isotype:	IgG (4) IgG2a (6) IgG2b (1)
Conjugation:	Non-conjugated (12)
Clonality:	Monoclonal (8) Recombinant (4)
Modification:	Unmodified (8)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P83984

	P4HB Antibody (YA3681) DSI,GIT,PDI,PHDB,PDIA1,PO4DB,PO4HB,PROHB,CLCRP1,ERBA2L,P4Hbeta	WB, IHC-P, FC, ELISA	Human
	P4HB Antibody (YA3681) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to P4HB.

HY-P83985

	P4HB Antibody (YA3682) DSI,GIT, PDI,PHDB, PDIA1,PO4DB, PO4HB,PROHB,CLCRP1, ERBA2L,P4Hbeta	WB, IHC-P, ICC/IF, FC, ELISA	Human
	P4HB Antibody (YA3682) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to P4HB.

HY-P81758

	P4HB Antibody (YA1503) P4HB; DSI; ERBA2L; GIT; P4Hbeta; PDI; PDIA1; PHDB; PO4DB; PO4HB; PROHB	WB, IHC-F, IHC-P, ICC/IF	Human, Mouse, Rat
	P4HB Antibody (YA1503) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to P4HB.

HY-P83984A

	P4HB Antibody (YA3681)(PBS only) DSI,GIT,PDI,PHDB,PDIA1,PO4DB,PO4HB,PROHB,CLCRP1,ERBA2L,P4Hbeta	WB, IHC-P, FC, ELISA	Human
	P4HB Antibody (YA3681) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to P4HB.

HY-P83985A

	P4HB Antibody (YA3682)(PBS only) DSI,GIT, PDI,PHDB, PDIA1,PO4DB, PO4HB,PROHB,CLCRP1, ERBA2L,P4Hbeta	WB, IHC-P, ICC/IF, FC, ELISA	Human
	P4HB Antibody (YA3682) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to P4HB.

HY-P81758A

	P4HB Antibody (YA1503)(PBS only) P4HB; DSI; ERBA2L; GIT; P4Hbeta; PDI; PDIA1; PHDB; PO4DB; PO4HB; PROHB	WB, IHC-F, IHC-P, ICC/IF	Human, Mouse, Rat
	P4HB Antibody (YA1503) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to P4HB.

HY-P89080

	TSN Antibody (YA8764) BCLF-1; C3PO; RCHF1; REHF-1; TBRBP; TRSLN	IHC-P	Human, Mouse, Rat
	TSN Antibody (YA8764) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to TSN.

HY-P89080A

	TSN Antibody (YA8764)(PBS only) BCLF-1; C3PO; RCHF1; REHF-1; TBRBP; TRSLN	IHC-P	Human, Mouse, Rat
	TSN Antibody (YA8764) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to TSN.

HY-P82441

	Galectin 8 Antibody (YA2186) LGALS8; Galectin-8g; Galectin-8; PO66-CBP; PCTA-1; Gal-8; Galectin 8; PCTA1	WB, IHC-P, ICC/IF, IP, FC	Human
	Galectin 8 Antibody (YA2186) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Galectin 8.

HY-P85923

	Oct-2 Antibody (YA5615) class 2; Lymphoid restricted immunoglobulin octamer binding protein; Lymphoid-restricted immunoglobulin octamer-binding protein NF-A2; NF A2; Oct 2; Oct-2; Octamer binding transcription factor 2; Octamer-binding protein 2; Octamer-binding transcription factor 2; OTF-2; OTF2; PO2F2_HUMAN; POU domain; POU domain class 2 transcription factor 2; POU2F2; transcription factor 2	IHC-P, WB, ICC/IF, ELISA	Human, Mouse
	Oct-2 Antibody (YA5615) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to Oct-2.

HY-P86792

	BRN3A Antibody (YA6485) Brain specific homeobox/POU domain protein 3A antibody; Brain-3A antibody; Brain-specific homeobox/POU domain protein 3A antibody; Brn 3.0 antibody; BRN 3A antibody; Brn-3A antibody; Brn3 antibody; BRN3A antibody; class 4 antibody; FLJ13449 antibody; Brain specific homeobox/POU domain protein 3A antibody; Brain-3A antibody; Brain-specific homeobox/POU domain protein 3A antibody; Brn 3.0 antibody; BRN 3A antibody; Brn-3A antibody; Brn3 antibody; BRN3A antibody; class 4 antibody; FLJ13449 antibody; Homeobox/POU domain protein RDC 1 antibody; Homeobox/POU domain protein RDC-1 antibody; Homeobox/POU domain protein RDC1 antibody; Oct T1 antibody; Oct-T1 antibody; OctT1 antibody; PO4F1_HUMAN antibody; POU class 4 homeobox 1 antibody; POU domain antibody; POU Domain Class 4 Transcription Factor 1 antibody; POu4f1 antibody; RDC 1 antibody; RDC1 antibody; transcription factor 1 antibody;	IHC-F, IHC-P	Mouse
	BRN3A Antibody (YA6485) is a Rat -derived and non-conjugated monoclonal antibody, targeting to BRN3A.

HY-P86793

	BRN3A Antibody (YA6486) Brain specific homeobox/POU domain protein 3A antibody; Brain-3A antibody; Brain-specific homeobox/POU domain protein 3A antibody; Brn 3.0 antibody; BRN 3A antibody; Brn-3A antibody; Brn3 antibody; BRN3A antibody; class 4 antibody; FLJ13449 antibody; Brain specific homeobox/POU domain protein 3A antibody; Brain-3A antibody; Brain-specific homeobox/POU domain protein 3A antibody; Brn 3.0 antibody; BRN 3A antibody; Brn-3A antibody; Brn3 antibody; BRN3A antibody; class 4 antibody; FLJ13449 antibody; Homeobox/POU domain protein RDC 1 antibody; Homeobox/POU domain protein RDC-1 antibody; Homeobox/POU domain protein RDC1 antibody; Oct T1 antibody; Oct-T1 antibody; OctT1 antibody; PO4F1_HUMAN antibody; POU class 4 homeobox 1 antibody; POU domain antibody; POU Domain Class 4 Transcription Factor 1 antibody; POu4f1 antibody; RDC 1 antibody; RDC1 antibody; transcription factor 1 antibody;	IHC-F, IHC-P, WB	Mouse, Rat
	BRN3A Antibody (YA6486) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to BRN3A.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

PO

Inhibitors & Agonists

Fluorescent Dyes

Biochemical Assay Reagents

Peptides

NaturalProducts

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides

Natural
Products